The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
The Alzheimer’s Disease Mitochondrial Cascade Hypothesis
Open accessAbstract
We first proposed the mitochondrial cascade hypothesis of sporadic Alzheimer's disease (AD) in 2004. Our core assumptions were a person's genes determine baseline mitochondrial function and durability, this durability determines how mitochondria change with advancing age, and critical changes in mitochondrial function initiate other pathologies characteristic of AD. Since then several lines of investigation report data consistent with or supportive of our hypothesis. In particular, AD endophenotype studies suggest a strong maternal genetic contribution, and links between mitochondrial function, tau phosphorylation, and amyloid-beta (Abeta) amyloidosis are increasingly recognized. As predicted, AD therapies designed to reduce Abeta thus far have had at best very limited clinical benefits; our hypothesis identifies alternative therapeutic targets. While placing mitochondria at the apex of an AD cascade certainly remains controversial, it is increasingly accepted by the AD research community that mitochondria play an important role in the late-onset forms of the disease. Even if the mitochondrial cascade hypothesis proves incorrect, considering its assumptions could potentially advance our understanding of sporadic, late-onset AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Models based on early-onset, autosomal dominant AD may therefore provide limited insight into late-onset, non-autosomal dominant AD.”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [146]
In the citing paper
“In other words, toxic cascades in AD are not initiated by Aβ, but by mitochondria.”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [146]
In the citing paper
“If correct, the mitochondrial cascade hypothesis has several inconvenient implications. The main implication is that early-onset, autosomal dominant and late-onset, non-autosomal dominant AD cases do not share a common etiology.”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [146]
In the citing paper
“According to the hypothesis Aβ is not an “upstream” biomarker of AD, but is instead a “downstream” marker of evolving mitochondrial dysfunction.”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [146]
In the citing paper
“Accordingly, Aβ deposition within an aging brain simply indicates critical age-related changes are occurring.”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [146]
In the citing paper
“According to the mitochondrial cascade hypothesis, mitochondrial function constitutes the crucial link between brain aging and AD.”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [146]
In the citing paper
“It deviates from the amyloid cascade hypothesis by predicting age-related changes in mitochondrial function, rather than mutations or polymorphisms in APP or Aβ processing genes, primarily account for age-associated brain Aβ changes.”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [146]
In the citing paper
“When mitochondrial decline surpasses a threshold compensatory mechanisms fail and late-onset AD ensues.”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [146]
In the citing paper
“The mitochondrial cascade hypothesis proposes mitochondrial function declines with age, and this decline promotes some features of brain aging including Aβ accumulation.”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [146]
In the citing paper
“In contrast to the amyloid cascade hypothesis, which views Aβ as the primary upstream AD biomarker, the mitochondrial cascade hypothesis in general sees Aβ more as a downstream biomarker of brain aging.”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [146]
In the citing paper
“The mitochondrial cascade hypothesis proposes mitochondrial function declines with age, and this decline promotes some features of brain aging including Aβ accumulation.”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [146]
In the citing paper
“In this explanation, the mitochondrial function declines with age and leads to increased production of ROS [65,66].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · cited 1×
“basis of this relationship remains uncertain [99].”
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“For almost twenty years the amyloid cascade hypothesis has dominated Alzheimer’s disease (AD) thinking, modeling, and therapeutic development efforts [1].”
BackgroundGoate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“The amyloid cascade hypothesis was formulated after an AβPP mutation was reported in a family with autosomal dominant amyloid angiopathy, dementia, and AD-typical histology [4].”
BackgroundQuerfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 1×
“Two other genes, presenilin 1 and 2, also contain mutations in autosomal dominant AD and the presenilin proteins are reportedly part of the gamma secretase complex that processes APP [5,6,7,8].”
BackgroundPremature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734 · cited 3×
“This has led some investigators to speculate somatic mtDNA mutation contributes to age-related declines in mitochondrial function, and available data support this view [38, 50].”
BackgroundResultScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · cited 1×
“In autosomal dominant AD, mutations in each of these proteins are believed to shift APP processing towards Aβ42 [9].”
BackgroundCandidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Research works printed but not linked: 4
- [111]Johnson DK Wilkins CH Morris JC Accelerated Weight Loss May Precede Diagnosis in Alzheimer Disease Arch Neurol 2006 63 1312 1317 16966511
- [112]Stewart R Masaki K Xue QL Peila R Petrovitch H White LR Launer LJ A 32-Year Prospective Study of Change in Body Weight and Incident Dementia: The Honolulu-Asia Aging Study Archives of Neurology 2005 62 55 60 15642850
- [113]BarrettConnor E Edelstein SL CoreyBloom J Wiederholt WC Weight loss precedes dementia in community-dwelling older adults Journal of the American Geriatrics Society 1996 44 1147 1152 8855991
- [114]White H Pieper C Schmader K Fillenbaum G Weight change in Alzheimer's disease J Am Geriatr Soc 1996 44 265 272 8600194
Cited by
Sorted by citations
Items 501–562 of 562
서훈녕 (2018) · Seoul National University Open Repository (Seoul National University)
Panahzadeh, F., physical education, L., Mirnasuri, R., & Rahmati, M. (2020) · مجله علمی دانشگاه علوم پزشکی رفسنجان · doi:10.29252/jrums.19.5.485
Abdulgader, A. A. A. (2020) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2020.11.001582
“These phenomena promoted the development of atherosclerosis and plaque vulnerability [38].”
Backgroundالإفادة من أساليب الطباعة اليدويه فى تجسيم الخط الکوفي ايهاميا
عامر, م. م. ا., الإمام, ر. ع., طه, ح. ح., & سرور, ح. م. م. (2015) · Al-Mağallah Al-ʿilmiyyaẗ Li Kulliyyaẗ Al-Tarbiyyaẗ Al-Nawʿiyyaẗ - Ǧāmiʿaẗ Al-Munūfiyyaẗ · doi:10.21608/molag.2015.164265
المرکبات الفيتوکيميائية لثمار الفاکهة في مواجهة خطر انخفاض الدوبامين علي الکلى : دراسة هستولوجية
رصاص, ع. ب., مبارک, ع. ا. ص., & الهادي, ف. ع. ا. ع. (2015) · Al-Mağallah Al-ʿilmiyyaẗ Li Kulliyyaẗ Al-Tarbiyyaẗ Al-Nawʿiyyaẗ - Ǧāmiʿaẗ Al-Munūfiyyaẗ · doi:10.21608/molag.2015.164284
THE INFLUENCE OF MITOCHONDRIA IN ALZHEIMER DISEASE AND POSSIBLE ALTERNATIVE THERAPIES
(2021) · International Journal of Neuroscience Research · doi:10.28933/ijnr-2021-04-0606
Singulani, M. P. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2020.tde-23122020-202326
Young, R. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc242.pub2
Halevas, E. G., Katsipis, G., & Pantazaki, Α. A. (2019) · Springer eBooks · doi:10.1007/978-981-13-3759-8_7
Mitochondrial DNA and Alzheimer's Disease: A First Case-control Study of the Tunisian PopulationPreprint
Salem, N. B., Boussetta, S., de Rojas, I., Moreno–Grau, S., Montrreal, L., Mokni, N., Mahmoud, I., Younes, S., Daouassi, N., Frih-Ayed, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1036952/v1
Infection-Induced Systemic Inflammation and Dementia
Osafo, N., Dei, S. O., Akwei, N. A., & Yeboah, K. O. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_2
Therapeutic and immunomodulatory functions of the translocator protein in Alzheimer's disease
Fairley, L. H. (2022) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/160865
de Moraes, R. C. M. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2020.tde-15102021-215546
Investigating the Mammillary Bodies as an Early Target of Alzheimer's Disease
Martinson, C. (2023) · doi:10.15760/honors.1428
“The mitochondrial hypothesis describes the disease as stemming from the degeneration of mitochondrial activity, leading to the degeneration of neurons (Swerdlow et al., 2010).”
BackgroundCYPS & agrotóxicos: o que você precisa saber?
Kohls, V. N. D. G., Louro, I. D., & Meira, D. D. (2023) · doi:10.22533/at.ed.207230310
Kerr, N. R. (2023) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/97056
Hemodiyaliz Hastalarında Kateter İlişkili Enfeksiyon Etkenleri
Kaya, H. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1668
Menstrüel Siklusun Evrelerinin Uyku, İştah ve Vücut Ağırlığı Üzerine Etkileri
Özüpek, G., & Altay, S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1671
Metabolik Hastalıklarda Asprosinin Rolü
Akçılar, R. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1669
Metisilin Dirençli Staphylococcus aureus (MRSA)
Sağlam, M., Kılıç, İ. H., & Zer, Y. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1677
Fahrioğlu, S. L., Yılmaz, İ., & İlgi, S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1675
İyonlaştırıcı Olmayan Radyasyonun Yaşamımızdaki Yeri
Yavaş, M. C. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1673
Amiloid Beta Peptidler: in-vitro Alzheimer Hastalığı Toksisite Modellerinde Kullanımları
Kurt, S., & Çam, F. S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1678
Dalak Anatomisi ve Klinik Önemi
Erbek, E., & BOLATLI, G. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1674
Gebelikte Parasetamol (Asetaminofen) Kullanımı Güvenli mi?
Şen, F. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1676
Köse, H. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1670
Coşar, A. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1672
Sağlık Bilimleri Araştırmaları: Temel Tıp- IV
Kaya, H., Ibrahim Halil GAZIANTEP UNIVERSITY KILIC, Akçılar, R., Köse, H., Özüpek, G., Altay, İ. S., Coşar, A., Yavaş, M. C., Erbek, E., BOLATLI, G., et al. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384
Yerel bir virüsten Yeni Bir Epidemiye mi? Maymun Çiçeği Virüsü (Monkeypox) Virüsü Yapısı
Bozlak, Ç. E. B. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1681
Salmonella spp. Enfeksiyonları
Gümüşburun, S. A., Demirdöğen, Y., Vural, U., Boyraz, E. F., & Eslami, M. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1679
Effects of Radiofrequency Radiations on the Male Reproductive System
Yavaş, M. C. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1680
MITOCHONDRIAL TRANSPLANTATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE (REVIEW)
Zhdanova, D. Y., & Chaplygina, A. V. (2023) · Problems of Biological Medical and Pharmaceutical Chemistry · doi:10.29296/25877313-2023-11-11
Gluščević, S. V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27333-9.00009-9
Genetic regulators of neuronal survival across metabolic environmentsPreprint
Bennett, N. K., Soto-Muniz, Y., Meng, J. X., Lee, M., Yang, J. L., Flanigan, W., Pico, A. R., Jain, I. H., & Nakamura, K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.19.695350
A study of neurodegeneration and neuroprotection in Nothobranchius guentheri
Genade, T. (2012) · Open University of Cape Town (University of Cape Town)
Prevention of Brain Disorders by Nicotine
Alkadhi, K. A., Salim, S., & Alzoubi, K. H. (2013) · Springer eBooks · doi:10.1007/978-3-642-22144-6_178
Cheng, D., Su, L., Wang, X., Li, X., Li, L., Hu, M., & Lu, Y. (2021) · Figshare · doi:10.6084/m9.figshare.15139478
Wilson, C., Galeano, P., Remedi, M. M., Novack, G. V., Campanelli, L., Gastaldi, L., Miglietta, E. A., Rossi, A. H., Olivar, N., Brusco, L. I., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.08.674945
Hallucinogenic Therapy in Alzheimer’s Disease targeting Mitochondria-Associated Membranes
Minauro‐Sanmiguel, F., & Vargas-Pérez, H. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.02.028
Zhou, X., Zhao, Y., Huo, H., Cheng, W., Feng, A., & Wang, S. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1777079
“Hyperglycemia and insulin resistance may lead to changes in the processing of amyloid precursor protein or beta-amyloid (29).”
Beta-Amyloid Suppresses Mitochondrial ATP Production in Human Neuroblastoma Cells
Zagryadskaya, Y. A., Nesterov, S. V., Mitkevich, V. A., Kozin, S. A., Kryuchkova, A., Lomakina, G. Y., Karbyshev, M. S., Bocharov, E. V., Makarov, A. А., & Okhrimenko, I. S. (2026) · Biochemistry (Moscow) · doi:10.1134/s0006297925602060
Spiru, L., Thor, D., & Marzan, M.-D. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014900
Vijayalakshmi, P., Alex, A. M., Muthupandian, S., Desai, D., Jayaprakashvel, M., Singh, S. K., & Selvaraj, C. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.02.003
Characterization of novel mitochondrial modulators for the development of neuroprotective strategies
Lejri, I. (2016) · theses.fr (ABES) · doi:10.70675/92acb76bz3c28z48ebzb148zd851e13ec021
Auboyer, L. (2018) · theses.fr (ABES) · doi:10.70675/07243ef7zb974z4ad8z97d9zd046801798b1
“Il serait notamment intéressant de savoir sous quels aspects celui-ci est associé à la maladie et quel degré d’association est déterminé par un effet sur la fonction mitochondriale (Swerdlow et al., 2010).”
BackgroundUm, J., Choi, S. M., Kim, Y. Y., Shin, D. J., Yoo, E., Maeng, H., Nathan, A. B. P., Jo, J., Cho, J. H., & Yun, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-48974-6
Tekin, N., Şahin, F., Şahin, B., Kaya, Z. Z., Yılmaz, A., Graham, S. F., Serteser, M., & Baykal, A. T. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01848-2
Jannah, A. R., Hasegawa, M., Ham, J., Hara, N., Tsukie, T., Obinata, A., Kikuchi, M., Kasuga, K., Yamaguchi, H., Hamasaki, H., et al. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1815858
“Mitochondria are ubiquitous organelles present in virtually all cell types and have been reported to be aected across a wide range of neurodegenerative diseases, including AD (Swerdlow et al., 2010).”
Mitochondrial dysfunction in Alzheimer’s disease: connecting pathophysiology with neuroimaging
Hu, J., Lai, J., Zhang, B., Jiang, X., Ma, H. F., & Liu, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1748227
“Elevated ROS levels further induce mtDNA mutations and disrupt mitochondrial autophagy (mitophagy), potentially culminating in cellular energy crises and neuronal apoptosis (Schofield and Schafer, 2021; Swerdlow et al., 2010).”
Synaptic dysfunction as a major driver in Alzheimer's disease: Beyond the amyloid paradigm
Mierzwa, N., & Wężyk, M. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106858
Savignac, C., St‐Onge, F., Villeneuve, S., Badhwar, A., Taliun, S. A. G., Farhan, S., Geddes, M. R., Medina, Y. I., Poirier, J., Spreng, R. N., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102943
“59 In more recent years, evidence that A β alters mitochondrial functioning has revised the original hypothesis.”
Alzweiri, M. H., Agha, A. S. A. A., Qinna, N. A., AlDabet, G., Khassawna, T. E., & Aburjai, T. A. (2026) · Biomedicines · doi:10.3390/biomedicines14081823
“Within this framework, early amyloid and related biomarker changes are not sufficient to drive symptoms in isolation but may remain functionally tolerated until compensatory capacity declines below a critical threshold [165,167].”
Szabó, A., Farkas, S., Milu, A. E., Tóth, A., Török, B., Fazekas, C. L., Sipos, E., Lénárt, K., Bánrévi, K., Correia, P., et al. (2026) · npj Dementia · doi:10.1038/s44400-026-00112-9
“Thesepathologicalprocessesarecloselylinkedtooxidativestressand mitochondrial alterations, supporting the concept that cellular energetic imbalanceemergesearlyinthediseasecourse 5 – 7 .”
Li, X., Wan, R., Wu, Y., Zhao, Y., Chen, X., Li, Y., Yang, R., Zhang, D., Li, Q., & Luo, C. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103359
Cellular redox status is linked to olfactory alterations in cognitive decline
Lampinen, R., Afonin, A. М., Mussalo, L., Avesani, S., Závodná, T., Feneberg, E., Krejčík, Z., Topinka, J., Chew, S., Löppönen, H., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104393
“Oxidative stress is also connected to the pathological hallmark proteins and mitochondrial dysfunction observed in AD [18,19].”
Metabolic responses to O-GlcNAcase inhibition in AppNL-G-F mice
Ouyang, X., Tian, R., Benavides, G. A., Bell, M., Kramer, J. A., Qin, H., Smith, M. R., Jones, D. P., Go, Y., Darley-Usmar, V. M., et al. (2026) · Advances in Redox Research · doi:10.1016/j.arres.2026.100198
Shiao, Y. (2026) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2026.09.005
Erdogan, M. A., & Cakmak, A. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag528
“For Alzheimer’s disease, prioritized features included Oxidative phosphorylation , Glycolysis/gluconeogenesis , Cholesterol metabolism , and Sphingolipid metabolism (Max F1: 0.429), aligning with the mitochondrial cascade hypothesis and lipid dysregulation [ 41– 52].”
InfluentialMolecular and genetic basis of alzheimer’s disease and emerging treatment Modalities
Varshney, H., & Siddique, Y. H. (2026) · Neurodegenerative Disease Management · doi:10.1080/17582024.2026.2739332
Xiao, Y., Li, X.-Y., Ding, H., Wen, J.-X., Dai, Y.-X., Zhang, Y.-J., Li, S.-P., Wang, Y., Zhou, H.-J., Zhang, B.-M., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.109714
Investigating the role and regulation of human mitochondrial poly(A) polymerase
Wilson, W. C. (2013)
Metadata
- Authors
- Swerdlow, R. H., Burns, J. M., & Khan, S. M.
- Affiliations
- University of Kansas (US)
- Gencia (United States) (US)
- Corresponding author
- Swerdlow, Russell H.
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2010-06-03
- Volume
- 20
- Issue
- s2
- Pages
- S265-S279
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC2883665
- OpenAlex
- W1685999671
- Cited by
- 562
- References
- 145
- Citations by year
- 2026: 31 · 2025: 30 · 2024: 26 · 2023: 63 · 2022: 34 · 2021: 37 · 2020: 38 · 2019: 25 · 2018: 36 · 2017: 37 · 2016: 41 · 2015: 31 · 2014: 33 · 2013: 37 · 2012: 28
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG026374, R21AG029615, AG029615, AG022407, R01AG022407, R03AG026374)
- National Eye Institute (R21EY018474, EY018474)
- National Institute of Neurological Disorders and Stroke (K23NS058252)
- National Center for Research Resources (M01RR023940)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease
- MeSH terms
- Aging, Alzheimer Disease, Animals, Electron Transport Complex IV, DNA, Mitochondrial, Humans, Mitochondria, Models, Biological, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
